3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas

This study is ongoing, but not recruiting participants.

Study NCT00085371 Information provided by National Cancer Institute (NCI)

First Received: June 10, 2004 Last Updated: September 20, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications: